Published in Am J Pathol on October 01, 1998
Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum (2011) 0.99
Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther (2004) 0.95
A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest (1999) 0.91
Molecular composition and pathology of entheses on the medial and lateral epicondyles of the humerus: a structural basis for epicondylitis. Ann Rheum Dis (2004) 0.89
BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance. Arthritis Res Ther (2009) 0.86
Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan. Clin Exp Immunol (2005) 0.84
Expression of extracellular matrix molecules typical of articular cartilage in the human scapholunate interosseous ligament. J Anat (2006) 0.82
Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models. Clin Dev Immunol (2012) 0.79
Rheumatoid arthritis viewed using a headache paradigm. Arthritis Res (2000) 0.77
Infection and autoimmunity: Lessons of animal models. Eur J Microbiol Immunol (Bp) (2011) 0.76
Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model. Biomed Res Int (2014) 0.76
Cytotoxic T lymphocytes recognize and lyse chondrocytes under inflammatory, but not non-inflammatory conditions. Immunology (2003) 0.75
Cartilage-specific autoimmunity in animal models and clinical aspects in patients - focus on relapsing polychondritis. Arthritis Res (2002) 0.75
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease. Immunogenetics (2006) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell (1989) 3.57
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum (1987) 2.19
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum (1987) 1.66
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
Link protein cDNA sequence reveals a tandemly repeated protein structure. Proc Natl Acad Sci U S A (1986) 1.36
Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35
Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycan. J Biol Chem (1985) 1.21
Cartilage proteoglycan aggregates. The link protein and proteoglycan amino-terminal globular domains have similar structures. J Biol Chem (1987) 1.20
The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol (1992) 1.17
Immunopathologic role of proteoglycan antigens in rheumatoid joint disease. Scand J Immunol (1980) 1.16
Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. Biochem J (1991) 1.15
Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum (1990) 1.13
Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol (1982) 1.12
Collagen autoimmunity and arthritis. FASEB J (1988) 1.11
Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. Cell Immunol (1983) 1.11
Isolation of proteoglycan-specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol (1988) 1.05
Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency. Biochem J (1989) 1.04
Characteristics of the core protein of the aggregating proteoglycan from the Swarm rat chondrosarcoma. J Cell Biochem (1984) 1.03
N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage. J Biol Chem (1995) 1.02
Link protein and a hyaluronic acid-binding region as components of aorta proteoglycan. Biochem Biophys Res Commun (1980) 1.00
T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica). Eur J Immunol (1988) 0.98
Link protein shows species variation in its susceptibility to proteolysis. J Orthop Res (1992) 0.90
Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes. J Clin Invest (1998) 0.88
Characterization of proteoglycan-reactive T cell lines and hybridomas from mice with proteoglycan-induced arthritis. J Immunol (1992) 0.87
Immunity to cartilage link protein in patients with juvenile rheumatoid arthritis. J Rheumatol (1997) 0.85
Evolution of the hyaluronan-binding module of link protein. Biochem J (1993) 0.82
An N-terminal peptide from link protein is rapidly degraded by chondrocytes, monocytes and B cells. Eur J Biochem (1993) 0.82
The primary structure of human cartilage link protein. Nucleic Acids Res (1990) 0.78
A physical map of 30,000 human genes. Science (1998) 12.43
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest (1994) 3.30
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials (1992) 3.10
Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun (1995) 2.96
Lysolecithin and cell fusion. Nature (1970) 2.90
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest (2001) 2.90
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol (1998) 2.85
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest (1995) 2.67
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem (1985) 2.39
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum (1987) 2.19
Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest (1992) 2.10
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89
The role of soft connective tissue in the breakdown of pig articular cartilage cultivated in the presence of complement-sufficient antiserum to pig erythrocytes. II. Distribution of immunoglobulin G (IgG). Int Arch Allergy Appl Immunol (1973) 1.89
[Bypass techniques during the anhepatic stage of transplantation of the liver (author's transl)]. Ann Chir (1975) 1.83
Binding of the proteoglycan decorin to collagen type VI. J Biol Chem (1992) 1.83
Interobserver reliability in musculoskeletal ultrasonography: results from a "Teach the Teachers" rheumatologist course. Ann Rheum Dis (2005) 1.79
Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest (2001) 1.78
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol (1996) 1.69
Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest (1998) 1.66
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum (1987) 1.66
Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J (1985) 1.62
Localized right upper lobe edema. Chest (1995) 1.62
An immunoelectron microscope study of the organization of proteoglycan monomer, link protein, and collagen in the matrix of articular cartilage. J Cell Biol (1982) 1.60
Localization of proteoglycan monomer and link protein in the matrix of bovine articular cartilage: An immunohistochemical study. J Histochem Cytochem (1980) 1.59
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum (1999) 1.59
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum (2000) 1.57
Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med (1999) 1.56
Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am (1996) 1.55
Electron microscopic studies of cartilage proteoglycans. Direct evidence for the variable length of the chondroitin sulfate-rich region of proteoglycan subunit core protein. J Biol Chem (1982) 1.53
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum (2000) 1.47
Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (1978) 1.47
Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. Biochem J (1983) 1.46
Surface tension of the most popular models of water by using the test-area simulation method. J Chem Phys (2007) 1.43
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum (1987) 1.41
Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35
Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res (1996) 1.35
Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta (1980) 1.33
Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med (1991) 1.31
An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage (2000) 1.29
Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med (1973) 1.29
Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol (1984) 1.28
Action of concanavalin A on the attachment stage of phagocytosis by macrophages. Exp Cell Res (1971) 1.28
Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc Res Tech (1994) 1.27
Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem (1986) 1.26
Role of proteoglycans in endochondral ossification: immunofluorescent localization of link protein and proteoglycan monomer in bovine fetal epiphyseal growth plate. J Cell Biol (1982) 1.25
Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res (1980) 1.25
Proteoglycans from bovine nasal cartilage. Immunochemical studies of link protein. J Biol Chem (1980) 1.24
Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J (1986) 1.24
Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol (1987) 1.24
Altered distribution of lysosomal cathepsin D in ischemic myocardium. J Clin Invest (1977) 1.21
The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int (1992) 1.21
Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids (2008) 1.19
A comparative study of heavy metal concentration and distribution in deposited street dusts in a large and a small urban area: Birmingham and Coventry, West Midlands, UK. Environ Int (2003) 1.18
Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum (1984) 1.17
Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am J Pathol (1980) 1.17
Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum (1990) 1.17
The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol (1992) 1.17
Early post-traumatic osteoarthritis-like changes in human articular cartilage following rupture of the anterior cruciate ligament. Osteoarthritis Cartilage (2005) 1.16
Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature (1975) 1.16
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol (1992) 1.16
Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain. J Cell Biol (1987) 1.16
Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem (1983) 1.16
Withdrawing and withholding life support in the intensive care unit: a Spanish prospective multi-centre observational study. Intensive Care Med (2001) 1.16
Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res (1981) 1.15
Unsuitability of leucine naphthylamide for the histochemical demonstration of lysosomal proteolytic activity. Nature (1969) 1.15
Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological conditions. J Cell Sci (1974) 1.15
Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage (2001) 1.14
Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.14
The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. J Biol Chem (1989) 1.13
Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry (1992) 1.13
A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol (1996) 1.13
The human lumbar endplate. Evidence of changes in biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. Spine (Phila Pa 1976) (1996) 1.12
Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol (1982) 1.12
Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. Cell Immunol (1983) 1.11
Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporos Int (2003) 1.11
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11